Dose Insider / Analyses / Alcohol on a GLP-1

Drinking Alcohol on a GLP-1What the Labels Say and What the Studies Found

Updated November 20, 2026 · 21 min read · FDA labels 2026, NIAAA, five studies 2023-2025

None of the four labels of Ozempic, Wegovy, Zepbound and Mounjaro sets a rule about alcohol.

0.64hazard ratio for hospitalization for alcohol use disorder while on semaglutide, against periods off it, in a Swedish cohort
Hospital stays for alcohol useSwedish cohort, hazard ratio against time off the drugSemaglutide0.6Liraglutide0.7Medicines for alcohol use1.0Hospital stays for alcoholuseSwedish cohort, hazard ratio against time off thedrugSemaglutide0.6Liraglutide0.7Medicines for alcohol use1.0

A ratio below 1 means fewer hospital stays during use.

On this page

Three things on the labels bear on it all the same: pancreatitis, for which heavy drinking is a leading cause; low blood sugar in people who also take insulin or a sulfonylurea, which alcohol makes harder to notice; and nausea, which the nutrition advisory for these medicines says alcohol may worsen. The advisory's advice is to keep alcohol to a minimum. On the other side, a small randomized trial found that semaglutide reduced craving and the amount drunk per drinking day in people with alcohol use disorder, and large cohort studies link these medicines to fewer alcohol-related hospital stays. One standard drink is 14 grams of alcohol, and U.S. dietary guidance defines moderation as one a day or less for women and two or less for men.1,5,6,8,10,11

What the labels and the advisory say

We searched the full prescribing information and patient leaflets of all four medicines for the word alcohol. It appears only as an alcohol wipe or swab for the skin, as benzyl alcohol, an inactive ingredient in the tirzepatide vials, and in the old name of a liver disease, nonalcoholic steatohepatitis, that Wegovy is approved to treat. None of the labels lists alcohol as an interaction, a warning or a reason not to take the medicine.1,2,3,4

That silence is not a clearance, because three of the labels' warnings concern conditions that alcohol affects.

The fullest advice comes from a 2025 joint advisory of four U.S. medical societies on nutrition during GLP-1 therapy. It says alcohol use may worsen nausea and gastroesophageal reflux on these medicines and should be minimized.5 That is the only direct statement about alcohol in the sources written for people on these drugs, and it is advice from experts, not the result of a trial.

What counts as one drink

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines a U.S. standard drink as about 14 grams, or 0.6 fluid ounces, of pure alcohol. That is the amount in a 12-ounce can of regular beer at 5% alcohol, a 5-ounce glass of wine at 12%, or a 1.5-ounce shot of spirits at 40%. It adds that many light beers have about 85% as much alcohol as regular beer, and that a 12-ounce craft beer at 10% holds two standard drinks.6

For other drinks NIAAA gives the size that holds one standard drink: 8 to 10 ounces of malt liquor or a flavored malt beverage such as hard seltzer, 3 to 4 ounces of a fortified wine such as sherry or port, 2 to 3 ounces of a cordial, liqueur or aperitif, and 1.5 ounces of brandy or cognac. The size of a glass alone does not say how much alcohol is in it.6

The U.S. Department of Agriculture's food database gives the alcohol and calories of common servings.9

ServingAlcohol gStandard drinksCaloriesCarbohydrate g
Regular beer, 12 oz can13.91.015312.6
Light beer, 12 oz11.00.81035.8
Red wine, 5 oz15.61.11253.8
White wine, 5 oz15.11.11213.8
Spirits, 1.5 oz shot14.01.0970.0
Sweet dessert wine, 3.5 oz15.81.116514.1
Daiquiri, 2 oz13.91.01124.2
Pina colada, 4.5 oz14.01.024532.0
Coffee liqueur, 1.5 oz11.30.817524.3

USDA FoodData Central, SR Legacy, per serving. Standard drinks are the grams of alcohol divided by NIAAA's 14 grams.6,9

The calories are the part that matters for someone on a weight-loss medicine. A shot of spirits and a pina colada carry the same alcohol, and the cocktail carries two and a half times the calories. Most of the difference is sugar: the database lists 31.5 grams of sugars in the pina colada and 19.9 grams in a serving of coffee liqueur, against none in the shot. A 5-ounce glass of wine is about 125 calories, more than a medium banana at 105.9

One evening, countedNIAAA, USDA
I am
Drinks this evening
Within about

Log drinks with meals and doses in the app and see what a night out does to the next day.

Open the app

Each tap adds one serving from the table above, and a fourth tap removes it. The limits are NIAAA's and the Dietary Guidelines' for adults in general; none is specific to people on a GLP-1.

Moderate, binge and heavy drinking

Three definitions frame every other number on this page.

Pattern, in standard drinksWomenMen
Moderation, in a day1 or less2 or less
Binge, in about two hours4 or more5 or more
Heavy, on any day4 or more5 or more
Heavy, in a week8 or more15 or more
High-intensity, on one occasion8 or more10 or more

Dietary Guidelines for Americans 2020-2025; NIAAA.7,8

NIAAA adds that harms may be associated with any amount of drinking, and that the level of harm rises as the amount rises. It says binge drinking and heavy use, which together it calls alcohol misuse, raise the risk of alcohol use disorder over time, and that research links drinking to breast cancer at levels as low as one drink a day.7 None of these limits was written with GLP-1 medicines in mind, and none of the sources here suggests a different one for people taking them.

A week of drinksNIAAA, USDA
I am
Usual drink

The weekly threshold is NIAAA's definition of heavy drinking. Calories are from the USDA database for the serving shown in the table.

Does a drink feel different on a GLP-1?

Many people on these medicines say it does, and two small studies from the same research group at Virginia Tech have tried to measure it.

The first, published in 2023, had two parts. A machine-learning analysis of about 68,250 Reddit posts about semaglutide or tirzepatide sorted them into eight major themes, led by the effects of the medicines (30%), diabetes (21%) and weight loss (19%). Of the posts, 1,580 concerned alcohol, and 71% of those described reduced craving, less desire to drink, or other negative effects of drinking. The second part recruited 153 current drinkers with a body mass index of 30 or more, some taking semaglutide or tirzepatide for at least 30 days and some taking neither. The people on the medicines reported lower alcohol intake, fewer drinks per drinking episode, lower odds of binge drinking and lower scores on a standard screening test for alcohol problems, both against their own drinking before the medicine and against the control group. They also reported weaker stimulating and sedative effects from alcohol.13

The second study, published in 2025, gave 20 people with obesity a set dose of alcohol, half of them on a GLP-1 medicine and half not, and measured breath alcohol and how the drink felt. In the group on the medicine, breath alcohol and the felt effects rose more slowly, and the delay was not explained by nausea.14

A slower rise fits what the labels say about the stomach. All four state that the medicine delays gastric emptying.1,2,3,4 The 2025 study was a pilot of 20 people and the 2023 study relied on self-report, so neither shows how large the effect is for any one person or whether it changes how drunk someone gets in the end. What they do suggest is that the first drink may take longer to be felt, which is a reason not to judge the second one by the first.

Do people drink less? Five studies

The question has moved from anecdote to trials in two years. These are the studies we could open, from the smallest and most controlled to the largest.

StudyWhoMain finding
Randomized trial, JAMA Psychiatry 202548 adults with alcohol use disorder not seeking treatment, 9 weeks, low-dose semaglutide or placeboLess alcohol drunk in a laboratory session, fewer drinks per drinking day and less craving; no change in drinks per day or drinking days
Swedish cohort, JAMA Psychiatry 2025227,866 people with alcohol use disorder, 2006 to 2023, each compared with themselves on and off the drugHospitalization for alcohol use disorder: hazard ratio 0.64 on semaglutide, 0.72 on liraglutide
U.S. health records, Nature Communications 202483,825 patients with obesity, semaglutide against other weight-loss medicines50% to 56% lower risk of a first or recurrent diagnosis of alcohol use disorder over 12 months
Survey and Reddit analysis, Scientific Reports 2023153 drinkers with obesity; 68,250 postsLower self-reported intake and binge drinking on semaglutide or tirzepatide
Alcohol challenge, Scientific Reports 202520 people with obesitySlower rise in breath alcohol and in felt effects on a GLP-1 medicine

Hendershot 2025, Lähteenvuo 2025, Wang 2024, Quddos 2023, Quddos 2025.10,11,12,13,14

The randomized trial is the strongest evidence that the drug itself has an effect. It ran at a U.S. academic medical center from 2022 to 2024 and assessed 504 potential participants to enroll 48 adults with alcohol use disorder who were not seeking treatment, 71% of them women, with an average age of 39.9 years. Participants received semaglutide at 0.25 mg a week for four weeks, 0.5 mg for four weeks and 1 mg for one week, or placebo. The main test, done at the 0.5 mg dose, was a laboratory session after treatment in which participants could drink: those on semaglutide drank less alcohol and reached a lower peak breath alcohol concentration. In daily life, semaglutide did not change the average drinks per calendar day or the number of drinking days, but it reduced drinks per drinking day and weekly craving, and it predicted greater reductions in heavy drinking over time. In the smokers among the participants, it also predicted greater reductions in cigarettes per day. The authors called this initial evidence that justifies larger trials.10

The Swedish cohort used national registers of everyone aged 16 to 64 with a diagnosis of alcohol use disorder, followed for a median of 8.8 years. It compared each person's periods on a medicine with their own periods off it, which removes differences between people. During use of semaglutide, among 4,321 users, the risk of hospitalization for alcohol use disorder was 36% lower, and during use of liraglutide 28% lower. The medicines approved for alcohol use disorder, taken together, were associated with a much smaller reduction, a hazard ratio of 0.98. Semaglutide and liraglutide were also associated with fewer hospital stays for physical illness. Neither was associated with a change in suicide attempts: the hazard ratio for semaglutide was 0.55, with an interval from 0.23 to 1.30 that includes no difference. The cohort was large: 227,866 people, of whom 58.5% were hospitalized for alcohol use disorder at some point during follow-up.11

On the drug against off itLähteenvuo 2025
Outcome

A hazard ratio of 1 means no difference between periods on and off the medicine; 0.64 means a 36% lower rate during use. Everyone in this cohort had alcohol use disorder; the authors describe the result as applying to people who also had obesity or type 2 diabetes.

The U.S. health-record study compared 83,825 patients with obesity who started semaglutide or another weight-loss medicine. Over 12 months, semaglutide was associated with a 50% to 56% lower risk both of a first diagnosis of alcohol use disorder and of a recurrence in people who had one before. The authors found the same direction in men and women, across age groups and races, with and without type 2 diabetes, and in a separate group of 598,803 patients with type 2 diabetes.12

What the studies do and do not show

Four cautions come straight from the papers.

For someone deciding whether to have a drink tonight, none of this changes the arithmetic of standard drinks or the warnings above. For someone who struggles with alcohol, it is a reason to raise the subject with the prescriber, not a reason to treat a weight-loss prescription as treatment for drinking.

Pancreatitis

This is the risk that links alcohol and the medicine most directly. NIDDK lists the most common causes of both acute and chronic pancreatitis as gallstones, heavy alcohol use, genetic disorders of the pancreas and some medicines, and names heavy alcohol use and genetic disorders as the most common causes of the chronic form.15 All four GLP-1 labels warn that acute pancreatitis, including fatal cases, has been observed in people on these medicines.1,2,3,4

NIDDK describes how acute pancreatitis usually starts: pain that begins slowly or suddenly in the upper abdomen, sometimes spreads to the back, can be mild or severe, and may last for several days, with fever, nausea and vomiting, a fast heartbeat, or a swollen or tender abdomen. People with it usually look and feel seriously ill and need to see a doctor right away.15

The labels describe the sign to watch for: persistent or severe abdominal pain, sometimes spreading to the back, with or without nausea or vomiting. The patient leaflets tell people to stop the medicine and call their health care provider right away if it happens.1 Our page on stomach pain on a GLP-1 gives the trial numbers.

No source here measured whether drinking on a GLP-1 raises the risk of pancreatitis beyond what each does alone. Someone who has had pancreatitis, or who drinks heavily, has a reason to discuss both with the prescriber before starting.

Low blood sugar, if you take insulin or a sulfonylurea

The Ozempic and Mounjaro labels warn that the risk rises when they are combined with insulin or a sulfonylurea, and that a lower dose of the insulin or sulfonylurea may reduce it.3,4

Alcohol adds to that risk in two ways, according to NIDDK. It makes it harder for the body to keep blood glucose steady, especially if a person has not eaten in a while. And it can keep a person from feeling the first symptoms of low blood glucose, which can lead to severe symptoms. NIDDK's advice for people with diabetes is that if they drink, it is safer to eat some food at the same time.16 On a medicine that reduces appetite, drinking without food is easy to slip into, which makes that advice more than routine.

NIDDK lists the symptoms of low blood glucose: feeling shaky, hungry, tired, dizzy, lightheaded, confused or irritable, a fast or uneven heartbeat, a headache, and trouble seeing or speaking clearly. Several of those are easy to mistake for having had a drink. Its first step when blood glucose is below target is to take 15 to 20 grams of glucose or carbohydrates right away, such as four glucose tablets or half a cup of fruit juice, and to check again after 15 minutes. It also warns that blood glucose can drop during sleep and stay low for several hours.16 An evening of drinking followed by sleep is the situation in which that warning matters most, and a question for the prescriber who manages the insulin or sulfonylurea.

Nausea, reflux and the morning after

The advisory's reason for minimizing alcohol is the stomach: alcohol may worsen nausea and reflux on these medicines.5 Nausea is the most common reaction on all four labels, reported by 44% on Wegovy 2.4 mg and 25% to 29% on Zepbound, and it is most frequent while the dose is being raised.1,2 NIDDK lists alcoholic drinks among the foods and drinks commonly linked to reflux symptoms.17

The labels' warning about kidney injury makes vomiting more than an unpleasant morning. The majority of reported cases occurred in people who had nausea, vomiting or diarrhea leading to dehydration.1 Whatever the cause of the vomiting, the medicine or the evening, the fluid lost is the same. Our pages on nausea and burping and reflux cover what helps.

The advisory also notes that stomach side effects are more likely in the first weeks of treatment and with each dose increase.5 If alcohol is going to make them worse, those are the weeks it will show most.

Calories and weight

Alcohol is food energy that brings no protein and no fiber. By the USDA figures, five glasses of wine in a week add about 625 calories, and five pina coladas about 1,225. A light beer saves about 50 calories against a regular one and carries 0.8 of a standard drink instead of 1.9 The nutrition advisory names the risk of inadequate nutrient intake from reduced food intake among the real-world challenges of these medicines.5 Calories from drinks take room from a plate that is already smaller.

The Dietary Guidelines put it plainly: drinking less is better for health than drinking more. The weekly counter above shows the calories for your own usual drink.8

If you do drink: what the sources add up to

No source tested a plan for drinking on a GLP-1. Put side by side, the sources on this page point to the same few habits.

If drinking is a problem

NIAAA defines alcohol use disorder as a medical condition marked by an impaired ability to stop or control alcohol use despite adverse social, occupational or health consequences. It covers what people call alcohol abuse, dependence, addiction and alcoholism, and it can be mild, moderate or severe. NIAAA adds that lasting changes in the brain caused by alcohol misuse keep the disorder going and make people vulnerable to relapse.7

The studies above are encouraging for this group, and they are not a treatment plan. The Swedish cohort found the GLP-1 medicines associated with fewer hospital stays than the medicines approved for the disorder, and its authors wrote that clinical trials are urgently needed to confirm the finding.11 Someone who takes a GLP-1 and finds drinking hard to control has two questions for the prescriber: whether the GLP-1 is right for them, and what treatment for the drinking itself is available.

Before a drink, checkLabels, NIDDK, DGA
This applies to me
Or right now

The checks come from the labels, NIDDK, the Dietary Guidelines and the nutrition advisory. A page cannot assess you; your prescriber can.

Short answers to common questions

Can I drink alcohol on Ozempic?

The label does not forbid it. The nutrition advisory for GLP-1 therapy says alcohol may worsen nausea and reflux and should be minimized, and the label's warnings on pancreatitis and low blood sugar both bear on drinking.

How much is too much?

The Dietary Guidelines define moderation as 1 drink or less a day for women and 2 or less for men. NIAAA counts 4 or more drinks in about two hours for women, and 5 or more for men, as binge drinking.

Why do I feel drunk faster, or slower?

A 2025 pilot study of 20 people found that breath alcohol and the felt effects rose more slowly on a GLP-1 medicine. Survey participants reported weaker effects. Neither study measured how drunk people got in the end.

Does Ozempic reduce the urge to drink?

In a 9-week randomized trial of 48 people with alcohol use disorder, low-dose semaglutide reduced craving and drinks per drinking day. It is not approved for that use.

Does Zepbound or Mounjaro do the same?

The 2023 survey included tirzepatide users and found lower self-reported drinking. The trial and the large cohort studies concerned semaglutide and liraglutide.

Is a hangover worse?

No source here measured hangovers. The advisory says alcohol may worsen nausea, and vomiting adds to the fluid loss that the labels link to kidney injury.

Does it matter that Wegovy treats a liver disease?

Wegovy is approved for metabolic dysfunction-associated steatohepatitis (MASH), formerly called nonalcoholic steatohepatitis, with moderate to advanced liver fibrosis. The label gives no advice on drinking for people treated for it; that is a question for the doctor treating the liver.

How many calories are in a glass of wine?

About 125 for 5 ounces of red and 121 for white, by the USDA figures. A 12-ounce regular beer is about 153 and a light beer about 103.

Is the day of the shot a bad day to drink?

No source here says so. The labels say semaglutide peaks in the blood 1 to 3 days after a dose and tirzepatide at a median of 24 hours, and that nausea is most frequent in the weeks after a dose increase.

Should I skip my dose if I plan to drink?

None of the labels says so, and none of the sources here recommends changing the dose around drinking. That is a question for the prescriber.

Is alcohol a problem with the injection itself?

No. In the labels the word alcohol appears for the wipe used to clean the skin, as an inactive ingredient of the tirzepatide vials, and in the name of a liver disease.

How this page was built

Every number was read in its source on November 20, 2026. We searched the full text of the four current labels for alcohol. The standard drink and the drinking patterns come from NIAAA, the moderation limits from the Dietary Guidelines for Americans 2020-2025, and the alcohol and calories of each drink from the USDA's SR Legacy database. The five studies were read as their published abstracts. The links between alcohol and pancreatitis, low blood glucose and reflux come from NIDDK pages, and the advice for people on these medicines from the 2025 joint nutrition advisory.

The limits are these. No source here measured what drinking does to the side effects or risks of GLP-1 medicines in a controlled way. The trial of alcohol use disorder was small and used doses below those for weight loss, and the larger studies are observational. The drink values are single database entries and brands differ. This page does not suggest doses of any medicine or a safe amount to drink.

Sources

  1. WEGOVY (semaglutide) prescribing information, NDA 215256/S-025, revised June 2026. U.S. Food and Drug Administration; full text, including sections 5, 6.1 and 17. accessdata.fda.gov
  2. ZEPBOUND (tirzepatide) prescribing information, NDA 217806/S-041, revised August 2026. U.S. Food and Drug Administration; full text, including sections 5, 6.1 and 11. accessdata.fda.gov
  3. OZEMPIC (semaglutide) injection prescribing information, NDA 209637/S-039, revised May 2026. U.S. Food and Drug Administration; full text, including sections 5 and 12. accessdata.fda.gov
  4. MOUNJARO (tirzepatide) prescribing information, NDA 215866/S-052, revised April 2026. U.S. Food and Drug Administration; full text, including sections 5 and 11. accessdata.fda.gov
  5. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring) 2025;33:1475-1503. doi:10.1002/oby.24336
  6. National Institute on Alcohol Abuse and Alcoholism. What is a standard drink? Read November 20, 2026. niaaa.nih.gov
  7. National Institute on Alcohol Abuse and Alcoholism. Understanding alcohol drinking patterns. Read November 20, 2026. niaaa.nih.gov
  8. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9th edition, December 2020; chapter 4 and Appendix 1, Table A1-2. dietaryguidelines.gov
  9. U.S. Department of Agriculture, Agricultural Research Service. FoodData Central, SR Legacy (2018), read November 20, 2026: entries 168746, 168749, 173190, 174837, 174815, 173176, 169574, 168752 and 175097. fdc.nal.usda.gov
  10. Hendershot CS, Bremmer MP, et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 2025;82:395-405. doi:10.1001/jamapsychiatry.2024.4789
  11. Lähteenvuo M, Tiihonen J, Solismaa A, et al. Repurposing semaglutide and liraglutide for alcohol use disorder. JAMA Psychiatry 2025;82:94-98. doi:10.1001/jamapsychiatry.2024.3599
  12. Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nat Commun 2024;15:4548. doi:10.1038/s41467-024-48780-6
  13. Quddos F, Hubshman Z, Tegge A, et al. Semaglutide and tirzepatide reduce alcohol consumption in individuals with obesity. Sci Rep 2023;13:20998. doi:10.1038/s41598-023-48267-2
  14. Quddos F, Fowler M, de Lima Bovo AC, et al. A preliminary study of the physiological and perceptual effects of GLP-1 receptor agonists during alcohol consumption in people with obesity. Sci Rep 2025;15:32385. doi:10.1038/s41598-025-17927-w
  15. National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms and Causes of Pancreatitis. Last reviewed November 2017, read November 20, 2026. niddk.nih.gov
  16. National Institute of Diabetes and Digestive and Kidney Diseases. Low Blood Glucose (Hypoglycemia). Last reviewed July 2021, read November 20, 2026. niddk.nih.gov
  17. National Institute of Diabetes and Digestive and Kidney Diseases. Eating, Diet, and Nutrition for GER and GERD. Last reviewed July 2020, read November 20, 2026. niddk.nih.gov

Related analyses

Log drinks, doses and symptoms together, and see what a night out does to the next day.

Open Dose Insider